Decreasing proportion of extended-spectrum beta-lactamase among E. coli infections during the COVID-19 pandemic in France
Olivier Lemenand, T. Coëffic, S. Thibaut, Mélanie Colomb-Cotinat, J. Caillon, Gabriel Birgand
Topics & Concepts
PandemicCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Beta-lactamaseVirologyMicrobiologyMedicineBETA (programming language)BetacoronavirusBiologyEscherichia coliOutbreakInternal medicineComputer scienceInfectious disease (medical specialty)GeneticsGeneDiseaseProgramming languageAntibiotic Use and ResistanceAntibiotic Resistance in BacteriaUrinary Tract Infections Management